Jason Chesney
James Graham Brown Foundation Chair · University of Louisville School of Medicine
Credentials: · · ·
History
- 2001–2004
Hematology and Medical Oncology
- 1994–1998
Doctor of Medicine
Research
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy · 2016 · 4,439 citations
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
New England Journal of Medicine · 2015 · 2,283 citations
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Journal of Clinical Oncology · 2015 · 2,112 citations
- ST
40 papers
- RB
19 papers
- AK
8 papers · 1 as a resident
- DM
8 papers
6 papers
6 papers
6 papers
6 papers
Grants
- 2020–2025
Center for Cancer Immunology and Immunotherapy (CCII)
National Institute of General Medical Sciences · P20
PI · $14.1M · University of Louisville
- 2011–2017
Activation of Cyclin-Dependent Kinases by Fructose-2,6-Bisphosphate
National Cancer Institute · R01
Contact PI · $1.5M · University of Louisville
- 2016
Molecular Targets Phase III CoBRE
National Institute of General Medical Sciences · P30
Project lead · $1.2M · University of Louisville
- 2005–2011
Targeting of 6-Phosphofructo-2 Kinase in Cancer
National Cancer Institute · R56
Contact PI · $256.9K · University of Louisville
Clinical trials
- 2017–2018
Principal investigator · Unknown · Phase 1, Phase 2
Virogen Biotechnology Inc.
- 2014–2017
Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Principal investigator · Withdrawn · Phase 1, Phase 2
University of Louisville
- 2014–2020
Principal investigator · Completed · Phase 1, Phase 2
MedImmune LLC
- 2014
Principal investigator · Terminated · Phase 1, Phase 2
Virogen Biotechnology Inc.